A detailed history of Nemes Rush Group LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Nemes Rush Group LLC holds 2,648 shares of ABT stock, worth $302,692. This represents 0.04% of its overall portfolio holdings.

Number of Shares
2,648
Previous 2,676 1.05%
Holding current value
$302,692
Previous $278 Million 8.24%
% of portfolio
0.04%
Previous 0.04%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$100.07 - $118.13 $2,801 - $3,307
-28 Reduced 1.05%
2,648 $301 Million
Q2 2024

Aug 15, 2024

BUY
$100.73 - $112.44 $402 - $449
4 Added 0.15%
2,676 $278 Million
Q1 2024

May 15, 2024

SELL
$109.52 - $120.96 $13,909 - $15,361
-127 Reduced 4.54%
2,672 $304 Million
Q4 2023

Feb 09, 2024

SELL
$90.19 - $110.4 $22,547 - $27,600
-250 Reduced 8.2%
2,799 $308 Million
Q3 2023

Nov 09, 2023

SELL
$95.53 - $114.62 $5,349 - $6,418
-56 Reduced 1.8%
3,049 $295 Million
Q2 2023

Aug 02, 2023

BUY
$100.78 - $112.29 $312,921 - $348,660
3,105 New
3,105 $338 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $200B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Nemes Rush Group LLC Portfolio

Follow Nemes Rush Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nemes Rush Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nemes Rush Group LLC with notifications on news.